Executive Director, Epidemiology, Clinical Safety and Pharmacovigilance
Daiichi Sankyo, Inc.
Maribel Salas, MD, MSc, DSc, FACP, FISPE
Dr. Salas is an Executive Medical Director, Head of Epidemiology and Cardiovascular Therapeutic Area, Daiichi Sankyo Inc., and Adjunct Scholar at the University of Pennsylvania. She has experience in Pharmacoepidemiology, Pharmacovigilance, Pharmacoeconomics, Clinical Epidemiology and Outcomes Research. Dr. Salas is a medical doctor and epidemiologist with more than 20 years of experience in pharmacovigilance and pharmacoepidemiology. Dr. Salas hold degrees in Medicine, Outcomes Research, Epidemiology, Clinical Epidemiology and Pharmacoepidemiology. At the International Society of Pharmacoepidemiology (ISPE), Dr. Salas is an active member, supporting the Global Development Committee including the RIGs in the Latin American and African regions. She organized the 1st Latin America Meeting in Mexico City (2009) and co-Chair the Mid-Year Meeting in Miami, Florida (2012). Dr. Salas worked in the Internal Medicine Department at the National Medical Center. She also worked at the Department of Preventive Medicine and School of Public Health (SOPH), University of Alabama at Birmingham. At the SOPH, Dr. Salas developed the Pharmacoepidemiology program and represented the Birmingham Center for Education, Research and Therapeutics (CERTs) at the CERTs National Educational Consortium. As pharmacoepidemiologist, Dr. Salas wanted to get experience in the pharmaceutical industry, and she joined the Patient Safety Departments at AstraZeneca Pharmaceuticals, Pfizer Inc, Merck Research Laboratories, and lately Daiichi Sankyo Incorporation, where she is responsible for the development of the Global Pharmacoepidemiology Department, CSPV. Dr. Salas obtained various federal grants, worked with multiple large databases, published more than 60 scientific articles in peer-reviewed journals and has more than 800 citations in the scientific literature.
